Importance of ELABELA in the differential diagnosis of benign and malignant lesions of the thyroid gland

ABSTRACT Objective: This study investigated whether ELABELA plays a role in the differential diagnosis of benign and malignant lesions of the thyroid gland. Subjects and methods: Of the 87 patients included in the study, 12 had undergone surgery for benign thyroid diseases, 30 had papillary thyroid cancer without invasion and/or lymph node metastasis in the surrounding tissues in the pathology report, and 45 had papillary thyroid cancer with invasion and/or lymph node metastasis in the surrounding tissues. Results: In the macrocarcinoma group, the proportion of patients with severe ELABELA staining (61.1%) was higher than that in the adenoma (50%) and microcarcinoma (23.8%) groups, while the proportion of those with mild to moderate staining was lower (p < 0.001). In the microcarcinoma group, the proportion of patients with severe staining was lower than that in the adenoma group, while the proportion of those with mild to moderate staining was higher (p < 0.001). In papillary thyroid carcinomas, the rates of moderate and severe staining in the classical variant, mild staining in the follicular variant, severe staining in the classical + follicular variant, and severe staining in the oncocytic variant were higher. Conclusion: To the best of our knowledge, this study is the first to be conducted on this subject. In this study, ELABELA was not found to be significant in the differential diagnosis of benign and malignant lesions of the thyroid gland. In papillary thyroid carcinomas, severe ELABELA staining patterns were more common in macrocarcinoma patients than in microcarcinoma patients.

Saved in:
Bibliographic Details
Main Authors: Bankir,Mehmet, Abayli,Cansu, Acibucu,Fettah
Format: Digital revista
Language:English
Published: Sociedade Brasileira de Endocrinologia e Metabologia 2020
Online Access:http://old.scielo.br/scielo.php?script=sci_arttext&pid=S2359-39972020000600772
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S2359-39972020000600772
record_format ojs
spelling oai:scielo:S2359-399720200006007722021-02-25Importance of ELABELA in the differential diagnosis of benign and malignant lesions of the thyroid glandBankir,MehmetAbayli,CansuAcibucu,Fettah Apelin APJ thyroid toddler ABSTRACT Objective: This study investigated whether ELABELA plays a role in the differential diagnosis of benign and malignant lesions of the thyroid gland. Subjects and methods: Of the 87 patients included in the study, 12 had undergone surgery for benign thyroid diseases, 30 had papillary thyroid cancer without invasion and/or lymph node metastasis in the surrounding tissues in the pathology report, and 45 had papillary thyroid cancer with invasion and/or lymph node metastasis in the surrounding tissues. Results: In the macrocarcinoma group, the proportion of patients with severe ELABELA staining (61.1%) was higher than that in the adenoma (50%) and microcarcinoma (23.8%) groups, while the proportion of those with mild to moderate staining was lower (p < 0.001). In the microcarcinoma group, the proportion of patients with severe staining was lower than that in the adenoma group, while the proportion of those with mild to moderate staining was higher (p < 0.001). In papillary thyroid carcinomas, the rates of moderate and severe staining in the classical variant, mild staining in the follicular variant, severe staining in the classical + follicular variant, and severe staining in the oncocytic variant were higher. Conclusion: To the best of our knowledge, this study is the first to be conducted on this subject. In this study, ELABELA was not found to be significant in the differential diagnosis of benign and malignant lesions of the thyroid gland. In papillary thyroid carcinomas, severe ELABELA staining patterns were more common in macrocarcinoma patients than in microcarcinoma patients.info:eu-repo/semantics/openAccessSociedade Brasileira de Endocrinologia e MetabologiaArchives of Endocrinology and Metabolism v.64 n.6 20202020-12-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S2359-39972020000600772en10.20945/2359-3997000000293
institution SCIELO
collection OJS
country Brasil
countrycode BR
component Revista
access En linea
databasecode rev-scielo-br
tag revista
region America del Sur
libraryname SciELO
language English
format Digital
author Bankir,Mehmet
Abayli,Cansu
Acibucu,Fettah
spellingShingle Bankir,Mehmet
Abayli,Cansu
Acibucu,Fettah
Importance of ELABELA in the differential diagnosis of benign and malignant lesions of the thyroid gland
author_facet Bankir,Mehmet
Abayli,Cansu
Acibucu,Fettah
author_sort Bankir,Mehmet
title Importance of ELABELA in the differential diagnosis of benign and malignant lesions of the thyroid gland
title_short Importance of ELABELA in the differential diagnosis of benign and malignant lesions of the thyroid gland
title_full Importance of ELABELA in the differential diagnosis of benign and malignant lesions of the thyroid gland
title_fullStr Importance of ELABELA in the differential diagnosis of benign and malignant lesions of the thyroid gland
title_full_unstemmed Importance of ELABELA in the differential diagnosis of benign and malignant lesions of the thyroid gland
title_sort importance of elabela in the differential diagnosis of benign and malignant lesions of the thyroid gland
description ABSTRACT Objective: This study investigated whether ELABELA plays a role in the differential diagnosis of benign and malignant lesions of the thyroid gland. Subjects and methods: Of the 87 patients included in the study, 12 had undergone surgery for benign thyroid diseases, 30 had papillary thyroid cancer without invasion and/or lymph node metastasis in the surrounding tissues in the pathology report, and 45 had papillary thyroid cancer with invasion and/or lymph node metastasis in the surrounding tissues. Results: In the macrocarcinoma group, the proportion of patients with severe ELABELA staining (61.1%) was higher than that in the adenoma (50%) and microcarcinoma (23.8%) groups, while the proportion of those with mild to moderate staining was lower (p < 0.001). In the microcarcinoma group, the proportion of patients with severe staining was lower than that in the adenoma group, while the proportion of those with mild to moderate staining was higher (p < 0.001). In papillary thyroid carcinomas, the rates of moderate and severe staining in the classical variant, mild staining in the follicular variant, severe staining in the classical + follicular variant, and severe staining in the oncocytic variant were higher. Conclusion: To the best of our knowledge, this study is the first to be conducted on this subject. In this study, ELABELA was not found to be significant in the differential diagnosis of benign and malignant lesions of the thyroid gland. In papillary thyroid carcinomas, severe ELABELA staining patterns were more common in macrocarcinoma patients than in microcarcinoma patients.
publisher Sociedade Brasileira de Endocrinologia e Metabologia
publishDate 2020
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S2359-39972020000600772
work_keys_str_mv AT bankirmehmet importanceofelabelainthedifferentialdiagnosisofbenignandmalignantlesionsofthethyroidgland
AT abaylicansu importanceofelabelainthedifferentialdiagnosisofbenignandmalignantlesionsofthethyroidgland
AT acibucufettah importanceofelabelainthedifferentialdiagnosisofbenignandmalignantlesionsofthethyroidgland
_version_ 1756441447806009344